Nonadherence to Antihypertensive Medication Among Hypertensive Adults in the United States─HealthStyles, 2010

Journal of Clinical Hypertension

Volumn 18, Issue 9, 2016, Pages 892-900

  Tong, Xin ^a   Chu, Elizabeth K ^a   Fang, Jing ^a   Wall, Hilary K ^a   Ayala, Carma ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DEPRESSION; DRUG COST; FEMALE; HISPANIC; HOUSEHOLD INCOME; HUMAN; HYPERTENSION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; TREATMENT REFUSAL; UNITED STATES;

EID: 85027918686     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12786     Document Type: Article

References (41)

1. Nwankwo T, Yoon SS, Burt V, et al. Hypertension among adults in the United States: national health and nutrition examination survey, 2011–2012. NCHS Data Brief. 2013;133:1–8.
2. Go AS, Mozaffarian D, Roger VL, et al. American Heart Association statistics committee and stroke statistics committee. Heart disease and stroke statistical update 2014: a report from the American Heart Association. Circulation. 2014;129:e28–e291.
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303:2043–2050.
4. Chobanian AV, Bakris G, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
5. Sanson-Fisher RW, Clover K. Compliance in the treatment of hypertension. A need for action. Am J Hypertens. 1995;8:82S–88S.
6. Gu Q, Dillon CF, Burt VL, et al. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010;23:38–45.
7. Levinthal BR, Morrow DG, Tu W, et al. Cognition and health literacy in patients with hypertension. J Gen Intern Med. 2008;23:1172–1176.
8. Lewis LM, Ogedegbe G. Understanding the role and nature of spirituality in reference to medication adherence: a proposed conceptual model. Holist Nurs Pract. 2008;22:261–267.
9. Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86:1805–1808.
10. Ndumele CD, Shaykevich S, Williams D, et al. Disparities in adherence to hypertensive care in urban ambulatory settings. J Health Care Poor Underserved. 2010;21:132–143.
11. Ogedegbe G, Harrison M, Robbins L, et al. Barriers and facilitators of medication adherence in hypertensive African-Americans: a qualitative study. Ethn Dis. 2004;14:158.
12. Polinski JM, Kesselheim A, Frolkis JP, et al. A matter of trust: patient barriers to primary medication adherence. Health Educ Res. 2014;29:755–763.
13. Gerin W, Tobin JN, Schwartz JE, et al. The medication adherence and blood pressure control (ABC) trial: a multi-site randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population. Contemp Clin Trials. 2007;28:459–471.
14. Marentette MA, Gerth WC, Billings DK, et al. Antihypertensive persistence and drug class. Can J Cardiol. 2002;18:649–656.
15. Miller NH, Hill M, Kottke T, et al. The multi-level compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085–1090.
16. Vawter L, Tong X, Gemilyan M, et al. Barriers to antihypertensive medication adherence among adults—United States, 2005. J Clin Hypertens (Greenwich). 2008;10:922–929.
17. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11:1–47.
18. AHRQ Report, Medication Adherence Interventions: Comparative Effectiveness, Closing the Quality Gap: Revisiting the State of the Science: Evidence Report No. 208. AHRQ Publication. 2012. 12(E010).
19. Gap CtC, Closing the Coverage Gap—Medicare Prescription Drugs are Becoming More Affordable. Department of Health and Human Services. 2015.
20. Gu Q, Burt VL, Dillon CF, et al. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension. Circulation. 2012;126:2105–2114.
21. Stewart SH, Silverstein MD. Racial and ethnic disparity in blood pressure and cholesterol measurement. J Gen Intern Med. 2002;17:405–411.
22. Traylor AH, Schmittdiel JA, Uratsu CS. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010;25:1172–1177.
23. Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2002.
24. Balcazar H, Alvarado M, Cantu F, et al. A promotora de salud model for addressing cardiovascular disease risk factors in the US-Mexico border region. Prev Chronic Dis. 2009;6:A02.
25. Balcazar HG, de Heer H, Rosenthal L, et al. A promotores de salud intervention to reduce cardiovascular disease risk in a high-risk Hispanic border population. Prev Chronic Dis. 2010;7:A28.
26. Morrison VL, Holmes EA, Parveen S, et al. Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey. Value Health. 2015;18:206–216.
27. Cha E, Erlen JA, Kim KH, et al. Mediating roles of medication-taking self-efficacy and depressive symptoms on self-reported medication adherence in persons with HIV: a questionnaire survey. Int J Nurs Stud. 2008;45:1175–1184.
28. Dempe C, Junger J, Hoppe S, et al. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. J Psychosom Res. 2013;74:122–127.
29. Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007;30:2222–2227.
30. Weidenbacher HJ, Beadles CA, Maciejewski ML, et al. Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of Americans veterans. Patient Prefer Adherence. 2015;9:327–336.
31. Fleming D, Koh H, Roux AVD, et al. A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension. Institute of Medicine. 2010.
32. Applegate BW, Ames SC, Mehan DJ Jr, et al. Maximizing medication adherence in low-income hypertensives: a pilot study. J La State Med Soc. 2000;152:349–356.
33. Friden TR, Berwick DM. The “million hearts” initiative—preventing heart attacks and strokes. N Engl J Med. 2011;365:e27.
34. Clark NM, Nothwehr F, Gong M, et al. Physician-patient partnership in managing chronic illness. Acad Med. 1995;70:957–958.
35. Clark NM, Gong M. Management of chronic disease by practitioners and patients: are we teaching the wrong things? Br Med J. 2000;320:572–575.
36. Odegard PS, Carpinito G, Christensen DB. Medication adherence program: adherence challenges and interventions in type 2 diabetes. J Am Pharm Assoc (2003). 2013;53:267–272.
37. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34:692–697.
38. Leenen FH, Wilson TW, Bolli P, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol. 1997;13:914–920.
39. Morisky DE, DeMuth NM, Field-Fass M, et al. Evaluation of family health education to build social support for long-term control of high blood pressure. Health Educ Q. 1985;12:35–50.
40. Pladevall M, Brotons C, Gabriel R, et al. A multi-center cluster-randomized trial of a multi-factorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation. 2010;122:1183–1191.
41. Cutrona SL, Choudhry NK, Fischer MA, et al. Modes of delivery for interventions to improve cardiocvascular medication adherence: review. Am J Manag Care. 2010;16:929–942.